PDMS-based stretchable multi-electrode and chemotrode array for epidural and subdural neuronal recording, electrical stimulation and drug delivery

1. An implantable device for electrical and pharmaceutical stimulation of a central nervous system which is configured and arranged for implantation in an animal or human in an epidural or subdural space of a spinal cord, comprising:

a conformable substrate which is primarily composed of a flexible and stretchable polymer;

a plurality of flexible and stretchable electrodes and stretchable conductive leads embedded in the conformable substrate; and

microfluidic channels that are embedded in the conformable substrate, wherein the electrical and pharmaceutical stimulation is applied to the spinal cord, epidurally or subdurally,

wherein the stretchable conductive leads are essentially made of a polymer matrix with an electrically conductive filler material, wherein the filler material is at least one of Ag, Au, Cu, Pt, Ir, Al, Fe, Cr, Ni, C, In, Sn, and Ti; and

wherein the filler material is present in fibrous, particle, or nanotube form, further configured such that pharmaceuticals to the epidural or subdural space can be delivered through the microfluidic channels.

2. The device according to claim 1 , wherein at least one of the electrodes and leads are stretchable by at least 20% while maintaining their conductivity.

3. The device according to claim 1 , wherein the conformable substrate essentially consists of poly(dimethylsiloxane).

4. The device according to claim 3 , wherein at least one of the electrodes and leads essentially consist of conductive poly(dimethylsiloxane).

5. The device according to claim 1 , further comprising at least one of the following:

a reception means for contactless energy supply to the plurality of flexible and stretchable electrodes;

an electrical circuit embedded in the conformable substrate or attached to the conformable substrate; or

a battery configured to supply electricity to the plurality of flexible and stretchable electrodes.

6. The device according to claim 1 , having a total thickness of less than 1 mm.

7. The device according to claim 1 , wherein at least one of the electrodes and conductive leads is functionalized with a drug releasing coating.

8. The device according to claim 1 , further comprising a plurality of holes or other microstructures to improve fluid circulation and thermoregulation and/or to promote tissue ingrowth and/or to prevent inflammation when the device is implanted.

9. The device according to claim 1 , wherein the electrodes form a multi-electrode array for stimulating neural tissue.

10. The device of claim 1 , wherein at least one of the electrodes and leads are stretchable by more than 50% while maintaining their conductivity.

11. The device of claim 1 , wherein the microfluidic channels embedded in the conformable substrate are horizontal channels.

12. The device of claim 1 , wherein a first layer of the conformable substrate is non-conducting.

13. A method of neurostimulation, comprising:

implanting a device in an epidural or subdural space of a spinal cord of an animal or human, the device comprising:

a conformable substrate which is primarily composed of a flexible and stretchable polymer; and

a plurality of flexible and stretchable electrodes and stretchable conductive leads embedded in the conformable substrate, wherein the stretchable conductive leads are essentially made of a polymer matrix with an electrically conductive filler material, wherein the filler material is at least one of Ag, Au, Cu, Pt, Ir, Al, Fe, Cr, Ni, C, In, Sn, and Ti; and

wherein the filler material is present in fibrous, particle, or nanotube form, further configured such that drugs to the epidural or subdural space can be delivered through microfluidic channels embedded within the device;

the method further comprising:

stimulating neurons in the spinal cord by providing electrical signals to the electrodes or the conductive leads of the device configured and arranged for implantation in the epidural or subdural space of the spinal cord.

14. A method of drug delivery, comprising:

implanting a device in an epidural or subdural space of a spinal cord of an animal or human, the device comprising:

a conformable substrate which is primarily composed of a flexible and stretchable polymer; and

a plurality of flexible and stretchable electrodes and stretchable conductive leads embedded in the conformable substrate, wherein the stretchable conductive leads are essentially made of a polymer matrix with an electrically conductive filler material, wherein the filler material is at least one of Ag, Au, Cu, Pt, Ir, Al, Fe, Cr, Ni, C, In, Sn, and Ti; and

wherein the filler material is present in fibrous, particle, or nanotube form, further configured such that drugs to the epidural or subdural space can be delivered through microfluidic channels embedded within the device;

the method further comprising:

delivering drugs to the epidural or subdural space through the microfluidic channels embedded within the device.

15. A method of recording neuronal signals, comprising:

implanting a device in an epidural or subdural space of a spinal cord of an animal or human, the device comprising:

a conformable substrate which is primarily composed of a flexible and stretchable polymer; and

a plurality of flexible and stretchable electrodes and stretchable conductive leads embedded in the conformable substrate, wherein the stretchable conductive leads are essentially made of a polymer matrix with an electrically conductive filler material, wherein the filler material is at least one of Ag, Au, Cu, Pt, Ir, Al, Fe, Cr, Ni, C, In, Sn, and Ti; and

wherein the filler material is present in fibrous, particle, or nanotube form, further configured such that drugs to the epidural or subdural space can be delivered through microfluidic channels embedded within the device;

the method further comprising:

recording neuronal signals from the spinal cord received by the electrodes or the conductive leads of the device.